Carcinogenicity Testing and the Evaluation of Regulatory Requirements for Pharmaceuticals-Reference-Cited by-同舟云学术

Carcinogenicity Testing and the Evaluation of Regulatory Requirements for Pharmaceuticals

Published:1997-04 Issue:2 Volume:25 Page:130-145
ISSN:0273-2300
Container-title:Regulatory Toxicology and Pharmacology
language:en
Short-container-title:Regulatory Toxicology and Pharmacology

Author:

Contrera Joseph F,Jacobs Abigail C,DeGeorge Joseph J

Publisher

Elsevier BV

Subject

Toxicology,General Medicine

Reference35 articles.

1. Transgenic models of tumor development;Adams;Science,1991

2. Definitive relationships among chemical structure, carcinogenicity and mutagenicity for 301 chemicals by the U.S. NTP;Ashby;Mutation Res.,1991

3. An overview of the Keystone Symposium on molecular toxicology, Copper Mountain, CO, 9–15 January 1995;Boyle;Human Exper. Toxicol.,1995

4. Genetic changes in skin tumor progression: Correlation between presence of a mutant ras gene and loss of heterozygosity on mouse chromosome 7;Bremner;Cell,1990

5. Pigmentosum and Cockayne syndrome;Cleaver,1994

Cited by 112 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Misconceptions about the Causes of Cancer;Human and Ecological Risk Assessment;2024-04-05

2. Critical Aspects of Integrated Nonclinical Drug Development: Concepts, Strategies, and Potential Pitfalls;A Comprehensive Guide to Toxicology in Nonclinical Drug Development;2024

3. EMA commentary on the ICH guideline for testing for carcinogenicity of pharmaceuticals;British Journal of Clinical Pharmacology;2023-06-02

4. Carcinogenicity Assessment;Haschek and Rousseaux's Handbook of Toxicologic Pathology, Volume 2 : Safety Assessment Environmental Toxicologic Pathology;2023

5. CARCINOGENICITY STUDIES;Drug Safety Evaluation;2022-12-23